We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$99B
AUM Growth
+$5.31B
Cap. Flow
-$322M
Cap. Flow %
-0.32%
Top 10 Hldgs %
14.08%
Holding
2,651
New
81
Increased
1,135
Reduced
556
Closed
97

Sector Composition

Rank Sector Weight
1 Healthcare 14.05%
2 Technology 13.96%
3 Financials 13.95%
4 Industrials 9.13%
5 Energy 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBRE icon
526
CBRE Group
CBRE
$42.5B
$32.4M 0.03%
1,011,081
+75,117
+8% +$2.17M
UNM icon
527
Unum
UNM
$13.6B
$32.1M 0.03%
923,655
+2,614
+0.3% +$89.3K
TXT icon
528
Textron
TXT
$14.7B
$32.1M 0.03%
837,108
+47,870
+6% +$1.88M
SITC icon
529
SITE Centers
SITC
$225M
$32M 0.03%
1,409,091
+204,304
+17% +$4.52M
FWONA icon
530
Liberty Media Series A
FWONA
$22.5B
$31.9M 0.03%
1,313,537
-10,132
-0.8% -$232K
TNL icon
531
Travel + Leisure Co
TNL
$4.66B
$31.9M 0.03%
932,918
+10,614
+1% +$348K
FOSL icon
532
Fossil Group
FOSL
$293M
$31.7M 0.03%
302,998
+22,511
+8% +$2.4M
WAT icon
533
Waters Corp
WAT
$37B
$31.6M 0.03%
302,103
+26,761
+10% +$2.81M
EQIX icon
534
Equinix
EQIX
$101B
$31.5M 0.03%
150,063
+13,199
+10% +$2.54M
RNR icon
535
RenaissanceRe
RNR
$13.3B
$31.5M 0.03%
294,485
+5,446
+2% +$558K
CMS icon
536
CMS Energy
CMS
$22.6B
$31.4M 0.03%
1,009,521
+89,717
+10% +$2.67M
IHS
537
DELISTED
IHS INC CL-A COM STK
IHS
$31.4M 0.03%
231,507
-1,837
-0.8% -$229K
LXRX icon
538
Lexicon Pharmaceuticals
LXRX
$1.03B
$31.4M 0.03%
2,782,588
+69,846
+3% +$750K
SWY
539
DELISTED
SAFEWAY INC
SWY
$31.2M 0.03%
908,392
-375,305
-29% -$12.8M
PLL
540
DELISTED
PALL CORP
PLL
$31.2M 0.03%
364,815
+15,383
+4% +$1.32M
EWJ icon
541
iShares MSCI Japan ETF
EWJ
$21.9B
$31.1M 0.03%
645,343
+110,590
+21% +$5.05M
SNPS icon
542
Synopsys
SNPS
$74.4B
$30.8M 0.03%
793,496
+44,919
+6% +$1.71M
AWK icon
543
American Water Works
AWK
$26.7B
$30.8M 0.03%
622,536
+93,770
+18% +$4.41M
HRB icon
544
H&R Block
HRB
$5.58B
$30.7M 0.03%
917,248
+58,487
+7% +$1.74M
TAP icon
545
Molson Coors Class B
TAP
$7.79B
$30.7M 0.03%
414,565
-3,123
-0.7% -$201K
AGCO icon
546
AGCO
AGCO
$7.15B
$30.7M 0.03%
545,621
-29,355
-5% -$1.62M
ITMN
547
DELISTED
INTERMUNE INC
ITMN
$30.5M 0.03%
691,197
-62,200
-8% -$2.29M
PVH icon
548
PVH
PVH
$4B
$30.4M 0.03%
260,526
+7,763
+3% +$966K
HLF icon
549
Herbalife
HLF
$1.29B
$30.1M 0.03%
934,118
+132,494
+17% +$4.06M
IPG
550
DELISTED
Interpublic Group of Companies
IPG
$29.9M 0.03%
1,534,390
-22,530
-1% -$409K

Similar funds

UBS AM's Q2 2014 Portfolio in Review

As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.

  • UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
  • UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
  • UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
  • UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
  • UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
  • UBS AM opened 81 new positions and closed 97 in Q2 2014.
  • UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.

Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.